Clinical Trial Update: Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat Schizophrenia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of iloperidone and risperidone for schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Iloperidone (iloperidone)
• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Schizophrenia, Iloperidone | Phase 2 | Status: COMPLETED